In last trading session, Enzo Biochem, Inc (NYSE:ENZ) saw 0.45 million shares changing hands with its beta currently measuring 0.83. Company’s recent per share price level of $0.76 trading at $0.05 or 7.05% at ring of the bell on the day assigns it a market valuation of $39.84M. That closing price of ENZ’s stock is at a discount of -80.26% from its 52-week high price of $1.37 and is indicating a premium of 10.53% from its 52-week low price of $0.68. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.29 million shares which gives us an average trading volume of 141.08K if we extend that period to 3-months.
Enzo Biochem, Inc (NYSE:ENZ) trade information
Upright in the green during last session for gaining 7.05%, in the last five days ENZ remained trading in the red while hitting it’s week-highest on Monday, 12/16/24 when the stock touched $0.76 price level, adding 26.21% to its value on the day. Enzo Biochem, Inc’s shares saw a change of -39.85% in year-to-date performance and have moved -25.23% in past 5-day. Enzo Biochem, Inc (NYSE:ENZ) showed a performance of -22.73% in past 30-days. Number of shares sold short was 0.42 million shares which calculate 2.8 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Enzo Biochem, Inc (NYSE:ENZ)’s Major holders
Insiders are in possession of 21.57% of company’s total shares while institution are holding 31.79 percent of that, with stock having share float percentage of 40.53%. Investors also watch the number of corporate investors in a company very closely, which is 31.79% institutions for Enzo Biochem, Inc that are currently holding shares of the company. HARBERT FUND ADVISORS, INC. is the top institutional holder at ENZ for having 5.18 million shares of worth $5.64 million. And as of 2024-06-30, it was holding 10.1064 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 2.5 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.8806 of outstanding shares, having a total worth of $2.72 million.
